↓ Skip to main content

Liver cell therapy: is this the end of the beginning?

Overview of attention for article published in Cellular and Molecular Life Sciences, November 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
106 Mendeley
Title
Liver cell therapy: is this the end of the beginning?
Published in
Cellular and Molecular Life Sciences, November 2017
DOI 10.1007/s00018-017-2713-8
Pubmed ID
Authors

Salamah M. Alwahsh, Hassan Rashidi, David C. Hay

Abstract

The prevalence of liver diseases is increasing globally. Orthotopic liver transplantation is widely used to treat liver disease upon organ failure. The complexity of this procedure and finite numbers of healthy organ donors have prompted research into alternative therapeutic options to treat liver disease. This includes the transplantation of liver cells to promote regeneration. While successful, the routine supply of good quality human liver cells is limited. Therefore, renewable and scalable sources of these cells are sought. Liver progenitor and pluripotent stem cells offer potential cell sources that could be used clinically. This review discusses recent approaches in liver cell transplantation and requirements to improve the process, with the ultimate goal being efficient organ regeneration. We also discuss the potential off-target effects of cell-based therapies, and the advantages and drawbacks of current pre-clinical animal models used to study organ senescence, repopulation and regeneration.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 16%
Researcher 17 16%
Student > Master 14 13%
Student > Bachelor 8 8%
Other 6 6%
Other 9 8%
Unknown 35 33%
Readers by discipline Count As %
Medicine and Dentistry 23 22%
Biochemistry, Genetics and Molecular Biology 18 17%
Agricultural and Biological Sciences 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Nursing and Health Professions 2 2%
Other 15 14%
Unknown 35 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2020.
All research outputs
#4,772,890
of 23,794,258 outputs
Outputs from Cellular and Molecular Life Sciences
#908
of 4,151 outputs
Outputs of similar age
#99,256
of 442,322 outputs
Outputs of similar age from Cellular and Molecular Life Sciences
#14
of 52 outputs
Altmetric has tracked 23,794,258 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,151 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,322 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.